Granulocytosis causing sickle-cell crisis

Lancet

Volumn 351, Issue 9107, 1998, Pages 959-

  Abboud, Miguel ^a,b   Laver, Joseph ^a,b   Blau, C Anthony ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HYDROXYUREA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; DOSE TIME EFFECT RELATION; FEMALE; GRANULOCYTOSIS; HUMAN; LEUKOCYTE COUNT; NEUTROPHIL; PRIORITY JOURNAL; SICKLE CELL CRISIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032495656     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60614-9     Document Type: Article

References (4)

1. 1 Shapiro BS, Ballas SK. The acute painful episode. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle cell disease: basic principles and clinical practice. New York: Raven Press, 1994: 531-43.
2. 2 Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-44.
3. 3 Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992; 79: 2555-65.
4. 4 Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317-22.